{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q96RI1",
      "entity_text" : "bar",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00356",
      "entity_text" : "vigiRank",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "A possible explanation is that vigiRank proposes a set of drug-ADR pairs for initial assessment that are of generally superior quality and so subconsciously raises the bar for what is going to be subjected to in-depth assessment.",
  "reading_complete" : "2020-08-05T21:35:36Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T21:35:09Z",
  "trigger" : "raises",
  "evidence" : [ "vigiRank proposes a set of drug-ADR pairs for initial assessment that are of generally superior quality and so subconsciously raises the bar" ],
  "pmc_id" : "5575476",
  "score" : 0
}